Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the immune-microbial axis in chronic ocular surface disease.

Current opinion in allergy and clinical immunology·2025
Same author

Bridging diagnostic gaps in anterior ocular inflammatory surface diseases.

Current opinion in allergy and clinical immunology·2025
Same author

From innovation to implementation: strengthening anterior ocular inflammatory surface diseases diagnostics through global health policy.

Current opinion in allergy and clinical immunology·2025
Same author

The Link Between Allergic Rhinitis and Keratoconus: A Call for Greater Awareness, Early Intervention, and Future Ocular Surface Diagnostic Tools.

The journal of allergy and clinical immunology. In practice·2024
Same author

The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist.

Current opinion in allergy and clinical immunology·2024
Same author

Ocular surface disorders: office procedures for the allergist/clinical immunologist.

Current opinion in allergy and clinical immunology·2024
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Related Experiment Video

Updated: May 29, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Ocular allergy.

Leonard Bielory1

  • 1Center for Environmental Prediction, Rutgers University, Springfield, NJ, USA. bielory@envsci.rutgers.edu

The Mount Sinai Journal of Medicine, New York
|September 14, 2011
PubMed
Summary
This summary is machine-generated.

Ocular allergic inflammation is common due to the eye's lack of barriers. Advancements in treatments and a collaborative "immuno-ophthalmology" approach are improving patient outcomes for red eye and related allergic conditions.

More Related Videos

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

Related Experiment Videos

Last Updated: May 29, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

Area of Science:

  • Ophthalmology
  • Allergy and Immunology

Background:

  • The eye is a frequent site for allergic inflammatory disorders, often presenting as
  • red eye,
  • due to direct allergen exposure.
  • Ocular allergies frequently coexist with other allergic conditions like asthma and eczema.
  • Ocular symptoms can be the most significant manifestation of a patient's overall allergic response.

Purpose of the Study:

  • To highlight the prevalence and significance of ocular allergic inflammation.
  • To discuss the evolution of diagnostic and therapeutic strategies.
  • To emphasize the benefits of a multidisciplinary approach in managing allergic eye disease.

Main Methods:

  • Review of recent therapeutic advances in managing ocular allergic inflammation.
  • Discussion of diagnostic challenges and improved differential diagnoses.
  • Emphasis on the collaborative
  • immuno-ophthalmology
  • model.

Main Results:

  • Significant therapeutic progress has been made over the past two decades.
  • Newer treatments include biologic immunomodulatory agents and advanced drug-delivery devices.
  • Surgical techniques are improving for sight-threatening complications.

Conclusions:

  • Ocular inflammation is becoming more manageable with current knowledge and treatments.
  • A team approach involving primary care physicians, ophthalmologists, and allergists/immunologists enhances patient outcomes.
  • The field of
  • immuno-ophthalmology
  • represents a significant advancement in patient care.